Clinical Trial Update: Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial investigating preoperative intravenous ferric carboxymaltose versus placebo in patients undergoing cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Aneurysm Thoracic
• Aortic Valve Stenosis
• Coronary Artery Disease
• Mitral Valve Disease
• Postoperative Complications

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Turku University Hospital | Conditions: Coronary Artery Disease, Postoperative Complications | Phase 4 | Status: UNKNOWN